Multicenter Stroke Preclinical Assessment Network Analysis of Cardiovascular Risk Factor Subgroups Treated With the Poly(ADP-Ribose) Polymerase Inhibitor Veliparib

Thrombosis and Stroke

Prognostic Factors for Long-Term Risk of Stroke After Transient Ischemic Attack or Minor Stroke: A Systematic Review and Meta-Analysis

Circulation

Khan F, Yogendrakumar V, Lun R, Marx CE, Rochwerg B, Tran A, Fernando SM, Ganesh A, Barber PA, Ögren J, Ois A, Giralt-Steinhauer E, Khanevski AN, Leng X, Tian X, Leung TW, Verburgt E, Verhoeven J, de Leeuw FE, Ildstad F, Fandler-Höfler S, Aarnio K, von Sarnowski B, Lorenzetti DL, Coutts SB, Amarenco P, Hankey GJ, Hill MD

doi: 10.1161/CIRCULATIONAHA.125.078763

Cardiovascular Risk and Diseases

Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial

JAMA Cardiol

Mulvagh SL, Inzucchi SE, Marx N, Poulter NR, Deanfield JE, Pop-Busui R, Emerson SS, Mann JFE, Engelmann MDM, Hovingh GK, Mandavya K, Davicevic-Elez Z, Jeppesen OK, Lorenzatti A, Oguz A, Mankovsky B, Deerochanawong C, Gorgojo-Martinez JJ, Ji L, Bain SC, McGuire DK, Buse JB, SOUL Study Group

doi: 10.1001/jamacardio.2026.0245

Cardiovascular Risk and Diseases

Comparative Effectiveness of Individual Sodium Glucose Transporter 2 Inhibitors on Cardiovascular Outcomes in Type 2 Diabetes With Moderate Cardiovascular Risk: Emulation of a Target Trial

J Am Heart Assoc

Zehra A, Deng Y, Swarna KS, Herrin J, Polley EC, Neumiller JJ, Galindo RJ, Umpierrez GE, Ross JS, Brito JP, Montori VM, Borah BJ, Maron BA, Mickelson MM, McCoy RG

doi: 10.1161/JAHA.125.046238

Further Publications

Frequent premature ventricular complexes and risk of atrial fibrillation, heart failure, stroke and mortality: a meta-analysis

Heart

Kiliç ME, Arayici ME, Yilancioglu RY, Turan OE, Ozcan EE, Yilmaz MB

doi: 10.1136/heartjnl-2025-326174

Heart, Artery and Coronary Diseases

Persistent gaps in management and risk factor control among patients with atherosclerotic cardiovascular disease: All of us research program

Atherosclerosis

Bene-Alhasan Y, Al Osta S, Issaka Y, Acquah I, Alkhatib A, Othman L, Mensah SO, Howard A, Ballantyne CM, Virani SS, Nambi V, Osei AD

doi: 10.1016/j.atherosclerosis.2026.120794

Atrial Fibrillation

Identification of Clinical Risk Factors for Arrhythmia Recurrence in Atrial Fibrillation Patients Undergoing Catheter Ablation: A Systematic review and Meta-analysis

Heart Rhythm

Chan KWP, Yu DSF, Ho JWK, Wong CWY, Li PWC

doi: 10.1016/j.hrthm.2026.04.046

Atrial Fibrillation

Biomarker-based ABC-AF Risk Scores for Personalized Treatment to Reduce Stroke or Death in Atrial Fibrillation - a Registry-based Multicenter Randomized Controlled Study

Circulation

Oldgren J, Hijazi Z, Arheden H, Björkenheim A, Frykman V, Janzon M, Ravn-Fischer A, Renlund H, Själander A, Åkerfeldt T, Wallentin L

doi: 10.1161/CIRCULATIONAHA.125.076725

COMMENTED

Cardiovascular Risk and Diseases

Risk differences and underlying factors of cardiovascular events and mortality in patients with type 2 diabetes versus type 1 diabetes: a longitudinal cohort study of Swedish nationwide register data

★ 1 Recommended and commented by Prof. emer. Dr Ulrich Keller, Faculty Member

Lancet Diabetes Endocrinol

Patsoukaki V, Lind L, Lampa E, Radhi S, Eeg-Olofsson K, Eliasson B, Eriksson JW

doi: 10.1016/S2213-8587(25)00165-2

Thrombosis and Stroke

Comprehensive Prestroke Risk Factor Control and Functional Outcomes After Acute Ischemic Stroke

J Am Heart Assoc

Kim JT, Lee JS, Kim H, Kim BJ, Kang J, Lee KJ, Park JM, Kang K, Lee SJ, Kim JG, Cha JK, Kim DH, Park TH, Lee K, Lee JY, Lee J, Kwon DH, Hong KS, Cho YJ, Park HK, Lee BC, Yu KH, Oh MS, Lee M, Kim DE, Gwak DS, Choi JC, Kwon JH, Kim WJ, Shin DI, Yum KS, Sohn SI, Hong JH, Park H, Lee SH, Kim C, Park MS, Ryu WS, Park KY, Heo SH, Lee J, Saver JL, Bae HJ

doi: 10.1161/JAHA.125.048491

Related content

Prognostic Factors for Long-Term Risk of Stroke After Transient Ischemic Attack or Minor Stroke: A Systematic Review and Meta-Analysis

Oral Semaglutide and Change in Cardiovascular Risk Factors in High-Risk Type 2 Diabetes: A Post Hoc Secondary Analysis of the SOUL Randomized Clinical Trial

Comparative Effectiveness of Individual Sodium Glucose Transporter 2 Inhibitors on Cardiovascular Outcomes in Type 2 Diabetes With Moderate Cardiovascular Risk: Emulation of a Target Trial

Frequent premature ventricular complexes and risk of atrial fibrillation, heart failure, stroke and mortality: a meta-analysis

Persistent gaps in management and risk factor control among patients with atherosclerotic cardiovascular disease: All of us research program

Identification of Clinical Risk Factors for Arrhythmia Recurrence in Atrial Fibrillation Patients Undergoing Catheter Ablation: A Systematic review and Meta-analysis

Biomarker-based ABC-AF Risk Scores for Personalized Treatment to Reduce Stroke or Death in Atrial Fibrillation - a Registry-based Multicenter Randomized Controlled Study

Risk differences and underlying factors of cardiovascular events and mortality in patients with type 2 diabetes versus type 1 diabetes: a longitudinal cohort study of Swedish nationwide register data

Comprehensive Prestroke Risk Factor Control and Functional Outcomes After Acute Ischemic Stroke